News

CLOs given green light on new therapy

A new therapy to treat inflammation and damage to the surface of the eye can now be issued by contact lens opticians (CLO).  

The Association of British Dispensing Opticians (ABDO) has confirmed that CLOs will be covered under their existing professional indemnity insurance to prescribe NuVision’s Omnigen and OmniLenz.  

The treatment options used dried placental tissue (amniotic membrane) that is applied to the eye’s surface and held in place using a bandage contact lens.  

ABDO said CLOs who undertook training provided by NuVision now had a new option to support patients with corneal damage and ocular surface disease. 

Register now to continue reading

Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.

Register

Already have an account? Sign in here